Fritextsökning
Artiklar per år
Innehållstyper
-
The winner of the race
She learned how to work hard at an early age and her devotion has certainly paid off. Whether it is field running or running a company, the key to success is focus according to Yvonne Mårtensson.
-
Sociala nervceller kan bota dövhet
Rörliga bilder på nervceller ger forskare nya perspektiv på hur nervceller beter sig. Resultaten kan komma att användas för att behandla hörselskador, exempelvis genom celltransplantation.
-
Hon är ny på Stockholm Science City
Stockholm Science Citys projekt Tools of Science har fått en ny projektansvarig.
-
En kvarts miljard till diabetesforskning
Ett Europeiskt konsortium ska särskilt studera komplikationer vid diabetes. Flera svenska lärosäten ingår i gruppen som får en svensk koordinator.
-
Ensamt på fritiden för gäststudenter
Internationella studenter är nöjda med nivån på de danska högskoleutbildningarna. Däremot är de mindre nöjda med den sociala miljön utanför föreläsningssalarna. Det visar en ny undersökning från danska vetenskapsministeriet.
-
Vetenskapsverktyg växer
Tools of Science omfattar inte längre bara Stockholm-Uppsalaregionen.
-
Forskningsstöd missgynnar kvinnor
Fler män får stöd, och de får i genomsnitt mer pengar. De danska forskningsrådens sätt att fördela pengar förstärker könsskillnaderna i forskningsvärlden, enligt en ny rapport.
-
Hundra miljoner ska ge friskare barn
Världens största centrum för barns hälsa och välmående ska byggas upp vid Köpenhamns universitet, efter en rekordstor donation.
-
Test if you carry the fat virus
In a soon future there may be a quick and simple test that could show if you are infected with Ad-36, a human adenovirus that can make you over-weight.
-
Orexo opens doors eastwards
The drug delivery company has signed a deal for selling a cancer pain treatment in China. "An ideal partner for us" says Torbjörn Bjerke, CEO of Orexo.
-
A smart company takes care of its best
Lundbeck didn't have to look far to find it's new international Director of Marketing. The talent was already in the house.
-
Almost 150 will leave Coloplast
The Danish medtech company Coloplast negotiates headcount reductions, with a total number of almost 150 employees.
-
Finnish-Dutch engineering cooperation continues
The University of Helsinki and ASM International renew a fice year research agreement on Atomic Layer Deposition.
-
Dako appoints new CEO
The Danish cancer therapeutic company Dako has appointed a new CEO after Patrik Dahlén.
-
Medtech companies find new beam technique
The medtech companies Raysearch and Nucletron expand collaboration with two new solutions for radiation treatment planning.
-
Eli Lilly writes biotech fine history
The American biotech company Eli Lilly will pay US 1.415 billion to resolve allegations of off-label promotion of a dementia drug.
-
Harmony prevents dementia
People who are active, outgoing and relaxed may be less likely to develop dementia, according to a new study from Karolinska Institutet.
-
Dupont gets new business manager
The Swedish API manufacturer Dupont Chemoswed has appointed a new business development manager.
-
Vitrolife wants to acquire Medicult
The Swedish company Vitrolife intends to make en exchange offer to the shareholders of the Danish company Medicult to acquire all outstanding shares in the company.
-
Parnevik firm in Swiss osteoporosis deal
The golf legend Jesper Parnevik's drug delivery firm EffRx has signed a license agreement with Nycomed for a new drug against osteoporosis.
-
DKK 1,3 billion for grand research
Danish Councils for Independent Research, DFF, will grant DKK 1,3 billion during 2009. Now has the application period started.
-
SDU professor helps EU
Mette Præst Knudsen from the University of Southern Denmark, SDU, has been appointed as an expert member in an EU politics group.
-
Bio-Linux goes global
Recently the NEBC Bio-Linux Version 5.0 was released, a one-stop shop for bioinformatics tools in a Linux context.
-
New Nordic nutrition collaboration
Scandinavian Clinical Nutrition has recently signed a unique Nordic distribution agreement.